Concentrics works with Alcon on successful switch of Pataday

Posted on February 24, 2020 by Clay Hosteter

Pataday switch announcement

Posted in Archives | Comments Off on Concentrics works with Alcon on successful switch of Pataday

Concentrics works with GSK on successful switch of Voltaren

Posted on February 24, 2020 by Clay Hosteter

https://www.fda.gov/news-events/press-announcements/fda-approves-three-drugs-nonprescription-use-through-rx-otc-switch-process

Posted in Archives | Comments Off on Concentrics works with GSK on successful switch of Voltaren

Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner

Posted on January 18, 2019 by Clay Hosteter

Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner

Posted in Concentrics News | Tagged , , | Comments Off on Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner